TenQ · Charts

AffirmAFRM

$24.4B market cap
AffirmAFRM
Revenue

Revenue: is the business selling more than it used to?

$1.4B+30% YoYFY 2026

0.00$1.0B20192020202120222023202420252026$1.4B

Revenue reached $1.4B in 2026, compounding +32% a year since 2023 and the pace is picking up.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

AffirmAFRM
Net income

Net income: how much of that revenue becomes profit?

$1.9B+3598% YoYFY 2026

0.00$2.0B20192020202120222023202420252026$1.9B

Net income was $1.9B in 2026, against $52M the year before. Earnings per share moved +3598% over the last twelve months.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

AffirmAFRM
Growth rate

How fast is it growing, year by year?

+29.6%revenue growth, FY 2026

0.0%50%100%2020202120222023202420252026Revenue growth 30%

Off the axis: 2026 earnings +3597.9% - rebounds off a collapsed prior year.

Revenue grew +30% in 2026 against a five-year average of +28%. 2026's +3598% earnings rebound off a collapsed base sits off the axis.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

AffirmAFRM
Per-share growth

Revenue per share: is your slice growing as fast as the company?

$4.14revenue per share, FY 2026

0.005.00201920202021202220232024202520264.142.85

Revenue per share reached $4.14 in 2026, compounding +25% a year against +32% for AFRM as a whole. Dilution absorbed about 7.1 points of that growth. Free cash flow per share stands at $2.85.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

AffirmAFRM
Free cash flow

Free cash flow: what is left in real cash after everything?

$993M+65% YoYFY 2026

0.00$500M$1.0B20192020202120222023202420252026$993M

Free cash flow was $993M in 2026. That is the most cash the business has ever thrown off in a year.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

AffirmAFRM
Cash conversion

How much of every sales dollar ends up as free cash?

0.0%2019202020212022202320242025202669%

69 cents of every sales dollar became free cash in 2026, up 86 points since 2023 - the best conversion in its filed history.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

AffirmAFRM
Spending intensity

What does staying competitive cost, per dollar of sales?

0.0%50%2019202020212022202320242025202617%21%

The biggest claim on each sales dollar is stock compensation, at 21% of revenue (capital spending 17%). That share has fallen since 2023, so the cost of competing is easing.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

AffirmAFRM
Margins

Margins: of every $1 of sales, how much survives each cost layer?

-200%0.0%2019202020212022202320242025202629%134%

Operating margin widened 220 points to 29% since 2023. After everything, 134 cents of each sales dollar reaches net profit. AFRM doesn't tag a gross-profit line in its filings, so the chart starts at operating margin.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

AffirmAFRM
Returns on capital

What does it earn on the money it uses?

0.0%2019202020212022202320242025202635%12%

AFRM earns 35% on shareholders' capital. Return on capital employed isn't meaningful for this business model, so ROE carries the picture alone.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

AffirmAFRM
Valuation history

What has the market paid for AFRM over time?

13.1xP/E today

0.0020.002021202220232024202520266-year median 16.4xP/S 16.91

2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages

At 16.9x sales, the market is paying about what it has typically paid AFRM's own 6-year median of 16.4x. Neither a bargain nor a stretch by its own standard.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

AffirmAFRM
Free cash flow yield

What cash return does the business throw off per dollar of market value?

4.1%FCF yield today

-2.5%0.0%2.5%2021202220232024202520266-year median 3.2%FCF yield 4.1%

2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages

Every dollar of market value currently buys 4.1% of annual free cash flow, more than its 6-year median of 3.2% - the cash is cheaper than usual.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

AffirmAFRM
Debt & cash

Could it handle its debt if things went wrong?

0.00$5.0B$10.0B201820192020202120222023202420252026$9.8B$1.6B

Debt of $9.8B sits against $1.6B of cash, or 1.8x shareholders' equity. Earnings cover interest only 0.9 times, which is thin.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

AffirmAFRM
Shareholders' equity

Is the company's own capital growing?

0.00$2.5B$5.0B201820192020202120222023202420252026$5.5B

The company's own capital grew from $2.6B in 2023 to $5.5B (+108%). The business is building book value rather than consuming it.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

AffirmAFRM
Capital returned

How much goes back, and how much leaks out as stock comp?

0.00$200M$400M201920202021202220232024202520262026

AFRM returned no cash to shareholders in the latest filed year: everything is being retained or reinvested.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

AffirmAFRM
Dilution rate

How fast is your ownership being diluted - or concentrated?

0.0%100%200%20202021233%202220232024202520262.3%

The share count grew 2.3% in 2026, averaging 5.8% a year over three years. Your slice of the company shrinks by that much each year unless earnings grow faster.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

AffirmAFRM
Dilution against what it bought

AFRM has issued or retired shares - did shareholders end up better off?

050020192020202120222023202420252026737140

AFRM's share count rose +637% from 2019 to 2026 while revenue per share grew +40%. Holders are further ahead than before, though the gain per share is smaller than the growth in the business.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

AffirmAFRM
Insider flow

Are the people running it buying or selling?

$5M0.00Apr '26May '26Jun '26Aug '26Sep '26

Insiders sold $23M on the open market and bought nothing. Many sales are pre-scheduled diversification rather than a view on the price. A further 49 filings were grants, option exercises or tax withholding, which say nothing either way.

Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30

A short weekly note on what changed in the numbers, coming soon.One email a week: the charts that mattered, nothing else.